ChromaDex Corp., an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, yesterday announced the signing of a letter of intent with Glanbia Nutritionals (NA), Inc. for distribution rights in North America of its patent pending pTeroPure® Pterostilbene. Glanbia Nutritionals will utilize its extensive market experience to serve as the primary distributor of ChromaDex’s recently launched BluScience™ line of dietary supplements made primarily with pTeroPure.
“Partnering with a large, exceptionally strong company like Glanbia is a tremendous next step in expanding pTeroPure’s adoption into numerous consumer products. With our upcoming human clinical data release and our various patents pending, in combination with Glanbia’s strong distribution base, we are now very well-positioned to more rapidly accelerate our national expansion of pTeroPure,” said William Spengler, President of ChromaDex in a press statement.
In 2010, pTeroPure was named as the North American Most Promising Ingredient of the Year. pTeroPure can be integrated into dietary supplements, nutritional products and foods that promote health and well being. It has many of the properties that occur naturally in blueberries which can improve the human defense system. One BlueScience dietary supplement made up of pTeroPure has the equivalent amount of Pterostilbene as contained in more than 500 cartons of blueberries and has shown great promise in supporting cardiovascular health, cognitive function and anti-aging. Additionally, it is better than blueberries in that it has better oral bioavailability, superior biological activity and metabolizes slower in the body, allowing more time for the antioxidants to activate.
“ChromaDex’s pTeroPure is an excellent addition to our product portfolio due to its superior bioavailability and range of potential health benefits,” said Richard Hazel, CEO of Glanbia Nutritionals (NA), Inc. in a press release. “The new distribution agreement will allow us to utilize our extensive market experience and national sales resources towards promoting ChromaDex’s innovative new product line and will benefit Glanbia Nutritionals by strengthening our position as a leader in the ingredients industry.”
Glanbia Nutritionals is a global supplier of nutritional ingredients, functional ingredients and customized premix solutions with over 4,300 employees worldwide. Glanbia Nutritionals touts its complete lines of vitamins, amino acids, colors and specialty nutritional ingredients that are made available to food, beverage, nutritional supplements and personal care manufacturers.
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment